Excellent article just published, based on the final degree thesis of @pgarciasegura: SARS-CoV-2 main protease (M-pro) mutational profiling: An insight into mutation coldspots. Computers in Biology and Medicine, vol. 184, Jan. 2025, 109344.
Our latest article "SARS-CoV-2 main protease (M-pro) mutational profiling: An insight into mutation coldspots" has just been published in Computers in Biology and Medicine. Congratulations to @pgarciasegura and @jmestrestruyol for their hard work.
https://t.co/3hEENZ06Gn
Our latest article has just been published in Drug Discovery Today. If you use protein-ligand docking during your VS, our work will help you get the most out of your calculations. Congratulations to @ariadnallop_ and Guillem Macip for their hard work.
https://t.co/2ZdDvMJBeA
Yesterday, our PhD student @bsaldivaremc2 defended his doctoral thesis titled "Application of machine learning methods on SARS-Cov-2: Mortality prediction by using health and nutritional factors and prediction of recurrent mutations".
Congratulations, Dr Saldivar !!!
Our article "Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition" doi:10.1002/med.21862 received enough citations to be a #TopCitedArticle in the journal Medicinal Research Reviews (IF 13.3)
Molt orgullosos que la nostra doctoranda @ariadnallop_ hagi rebut el Premi del Públic en l'onzena edició del concurs “Vols saber què investigo?” de monòlegs científics
Moltes felicitats Ariadna !!!
A. Llop-Peiró, G. Pujadas, S. Garcia-Vallvé. Challenges in distinguishing functional proteins from polyproteins in databases: implications for drug discovery. Briefings in Bioinformatics, Volume 25, Issue 2, March 2024, bbae012. https://t.co/MviZfeE1qg
A. Llop-Peiró, G. Pujadas, S. Garcia-Vallvé. Challenges in distinguishing functional proteins from polyproteins in databases: implications for drug discovery. Briefings in Bioinformatics, Volume 25, Issue 2, March 2024, bbae012. https://t.co/MviZfeE1qg
Our manuscript in collaboration with the research group of Prof. Armando Rossello (@Unipisa) is already published. We are happy to work with our Italian colleagues to find new drugs against osteoarthritis https://t.co/HyyuLKHD8I
Des de @cheminform_URV i ASCLEPIUS estem aprofitant tot el que hem après amb la COVID-19 per preparar-nos per ser més eficients en la cerca de fàrmacs contra noves pandèmies. Si vols saber com ho fem, escolta l'entrevista de @PabloAlcarazG#NEXT_PANDEMICS https://t.co/5BGsuomsqo
Buenos días comunidad! El #Paperperuano de esta semana trata sobre Redes Neuronales Artificiales (RNA) y sus aplicaciones. Llega gracias a la colaboracion de Bryan Saldivar @bsaldivaremc2, estudiante de doctorado en la Universidad Rovira I Virgili en Cataluña Abrimos hilo (1/7)
The SARS-CoV-2 mutational portal is out. It contains SARS-CoV-2 mutation data derived from the analysis of more than 4.5 million complete genomes available in GISAID. More info at https://t.co/YzsapXKzEW
Our first paper in collaboration with the ASCLEPIUS research group at URV is now available and opens the door to coupling quantitative prediction of bioactivity in virtual screening to find new non-covalent M-pro inhibitors of SARS-CoV-2. https://t.co/W494q23Zuf
New doctoral dissertation in our research group next Monday May 15: : "Studying the limits of protein-ligand docking to predict new non-covalent inhibitors for the SARS-CoV-2 main protease" by Guillem Macip Sancho.